According to a recent LinkedIn post from Impress, the company is highlighting external recognition for its co‑founder and COO, Diliara Lupenko, who has been included among Europe’s 100 most influential women in startups and venture capital by EU‑Startups. The post emphasizes her role in building operations, technology, and patient experience for the healthtech business.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post suggests that Impress operates with more than 1,000 employees across 10 countries, managing multiple regulatory environments and languages. For investors, this recognition of an operational leader may be interpreted as a signal of experienced management overseeing a relatively large, multi‑country platform in the orthodontics and broader healthtech space.
The post also underscores the complexity of running a pan‑European healthtech operation, which can imply both execution risk and potential for scaled efficiencies if managed well. Visibility from industry listings such as the EU‑Startups ranking may modestly enhance Impress’s brand among partners, talent, and investors, supporting its position in a competitive orthodontics and digital health market.